Not a labelled effect: where the documents stand
Foundayo™ is the brand name for orforglipron tablets, a once-daily GLP-1 receptor agonist; studies describe it as a small molecule rather than a peptide [9]. The label reports side effects from Trial 1 and Trial 2, the 72-week ATTAIN weight studies, and has no entry for brain fog, memory loss, poor concentration or confusion as a side effect [1]. Confusion appears only in the Medication Guide, as a possible sign of low blood sugar [2].
| Document | What is listed | Context |
|---|---|---|
| US Prescribing Information, Table 1 [1] | Fatigue 6% (5.5 mg), 7% (9 mg), 9% (17.2 mg) | Placebo 4%; includes related terms |
| US Prescribing Information, section 6.1 [1] | Dizziness 4%; low blood pressure 2% | Placebo 3% and 0.5% |
| US Medication Guide [2] | Confusion or drowsiness, slurred speech, blurred vision | Listed as signs of low blood sugar, not as side effects |
| European Medicines Agency [3] | Positive opinion on 15 October 2026; no summary of product characteristics yet | No EU frequency data |
| Health Canada [4] | No listing in the Drug Product Database | No monograph |
Single cases in the trial registries
Some orforglipron trials published every adverse event on ClinicalTrials.gov. Searching them for cognitive terms turns up a handful of reports, set out below. The ACHIEVE studies were in type 2 diabetes and used trial doses of 3, 12 and 36 mg; ATTAIN-1 used doses the label converts to 5.5, 9 and 17.2 mg [1].
| Term and trial [source] | Placebo or comparator | Orforglipron |
|---|---|---|
| “Brain fog”, ACHIEVE-1 [5] | 0 of 138 | 1 of 137 (12 mg) |
| Memory impairment, ACHIEVE-2 [6] | Dapagliflozin 0 of 240 | 1 of 241 (36 mg) |
| Memory impairment and confusional state, ACHIEVE-5 [7] | 0 of 140 | 1 of 132 each (12 mg) |
| Transient global amnesia, serious, ATTAIN-1 [8] | 0 of 948 | 1 of 723 (lowest dose) |
| Somnolence (sleepiness), ACHIEVE-1 [5] | 3 of 138 | 1 of 143, 2 of 137, 2 of 141 |
What those reports mean
- Each term affected one person in groups of 130 to 720. That is not enough to say whether orforglipron causes any of them.
- Sleepiness, the most frequent of these terms, was reported at least as often on placebo as on orforglipron in ACHIEVE-1 [5].
- ATTAIN-1 and ATTAIN-2 only published events that affected at least 5% of a group, so milder or rarer complaints in the weight trials are not visible [8].
- Registry entries give no detail on timing, duration or what else was going on, such as low blood sugar or illness.
How Foundayo™ could leave you foggy on a given day
Supported by the label: several listed effects can affect alertness. Fatigue is in Table 1 [1]. Low blood pressure occurred in 2% on Foundayo™ against 0.5% on placebo, and in 4% of those also on blood pressure medicines [1]. Vomiting and diarrhoea can cause dehydration [1], and MedlinePlus names confusion and irritability among signs of severe dehydration [12]. Low blood sugar was reported by 2% of people with type 2 diabetes on orforglipron in Trial 2 against 0.2% on placebo, rising to 7% in those also taking a sulfonylurea [1]; MedlinePlus lists unclear thinking among its symptoms [11].
Proposed but not measured: eating much less, or sleeping poorly in the first weeks of stomach side effects, could plausibly add to fogginess. Cleveland Clinic lists poor nutrition and lack of sleep among common causes of brain fog [10], but no Foundayo™ study has looked at this.
Laboratory evidence: the label states that orforglipron reached appetite-regulating brain areas in animals [1]. A 2026 study in human cell lines found protective effects on nerve cells and measured low brain uptake in rats, comparable to peptide GLP-1 drugs [9]. Cell and animal findings say nothing about how people think or feel on the tablet.
The usual suspects that are not the tablet
Cleveland Clinic and MedlinePlus list many causes of brain fog and confusion [10][13]:
- Too little sleep, including sleep disorders; 11% of people in the label’s trials had obstructive sleep apnoea [1].
- Anxiety, depression and stress.
- Hormonal shifts such as pregnancy and menopause.
- Infections, fever and the after-effects of COVID-19.
- Other medicines, alcohol and drugs, and withdrawal from them.
- Low vitamin B12, thiamine or niacin, and other nutritional gaps.
What general sources suggest
Cleveland Clinic notes that there is no specific treatment for brain fog and suggests better sleep habits, nutritious meals, regular physical activity, short breaks, and writing important things down [10]. It advises telling a provider when fog disrupts daily tasks, such as forgetting appointments or struggling to follow a conversation.
Before the first tablet, the Medication Guide asks every user to discuss low blood sugar, including how it is handled, with their provider, and to mention any insulin or sulfonylurea [2]. MedlinePlus says that sudden confusion from low blood sugar should be treated with a sweet drink or snack, and that a provider should be contacted if confusion lasts longer than 10 minutes [13].
For fluid loss, the Medication Guide asks you to drink fluids and to report nausea, vomiting or diarrhoea that does not go away [2].
Points specific to the tablet
Foundayo™ reaches a steady level in the body after about a week of daily dosing, and its half-life is about 29 to 49 hours [1]. That means effects linked to the drug level do not swing much from hour to hour, so a foggy morning that clears by lunch is less likely to reflect the tablet itself than food, fluid, sleep or blood sugar.
Doses go up no sooner than every 30 days [1]. Recording when fogginess started, compared with your dose steps and any stomach side effects, gives your prescriber a timeline.
Foundayo™ is a trademark of Eli Lilly and Company. PepLabo is not affiliated with or endorsed by Eli Lilly and Company.
When to get help
| Sign | Who to contact | How fast | Source |
|---|---|---|---|
| Confusion that comes on suddenly, especially in someone with diabetes, or for the first time without a reason | Emergency services (911 or your local number) | Emergency | MedlinePlus [13] |
| Confusion with fainting, a fast pulse, fever or cold, clammy skin | Emergency services | Emergency | MedlinePlus [13] |
| Confusion, drowsiness or slurred speech with sweating, shakiness or hunger | Treat low blood sugar as you were taught, then contact your provider | Today | Foundayo™ Medication Guide [2], MedlinePlus [13] |
| Feeling muddled or dizzy with very little urine after vomiting or diarrhoea | Your prescriber, right away | Today | Foundayo™ Medication Guide [2], MedlinePlus [12] |
| Brain fog that keeps disrupting work, appointments or conversations | Your healthcare provider | At your next appointment | Cleveland Clinic [10] |
